Guidance for the antithrombotic management of persons with haemophilia and cardiovascular disease

被引：0
|
作者：
Mannucci, Pier Mannuccio [1 ]
Agosti, Pasquale [2 ,3 ]
Lettino, Maddalena [4 ]
机构：
[1] Fdn IRCCS CaGranda Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[2] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
[3] Univ Milan, Fdn Luigi Villa, Milan, Italy
[4] Fdn IRCCS San Gerardo Tintori, Dept Cardiac Thorac & Vasc Dis, Monza, Italy
来源：
HAEMOPHILIA | 2023年 / 29卷 / 06期
关键词：
antithrombotic treatment; Cardiovascular disease; clinical practice guidance; ATRIAL-FIBRILLATION; PEOPLE; PATIENT; RISK;
D O I：
10.1111/hae.14874
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1390 / 1393
页数：4
相关论文
共 50 条
  • [31] Nattokinase: An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease
    Weng, Yunqi
    Yao, Jian
    Sparks, Sawyer
    Wang, Kevin Yueju
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (03):
  • [32] Cardiovascular disease prevalence and relevance in haemophilia: a scoping review
    Rizwan, I.
    Minuk, L.
    Jackson, S.
    Iorio, A.
    [J]. HAEMOPHILIA, 2015, 21 (03) : E156 - E166
  • [33] Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020
    Ramacciotti, Eduardo
    Macedo, Ariane Scarlatelli
    Biagioni, Rodrigo Bruno
    Caffaro, Roberto Augusto
    Lopes, Renato Delascio
    Guerra, Joao Carlos
    Orsi, Fernanda Andrade
    Marques, Marcos Areas
    Tafur, Alfonso J.
    Caprini, Joseph A.
    Nicolaides, Andrew
    Carter, Charles A.
    Carvalheiro Filho, Cyrillo
    Fareed, Jawed
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2020, 26
  • [34] Risk of Bleeding Related to Antithrombotic Treatment in Cardiovascular Disease
    Sorensen, Rikke
    Olesen, Jonas B.
    Charlot, Mette
    Gislason, Gunnar H.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (33) : 5362 - 5378
  • [35] Does haemophilia protect against ischaemic cardiovascular disease?
    Van de Putte, D. E. Fransen
    Fischer, K.
    Schutgens, R. E. G.
    Mauser-Bunschoten, E. P.
    [J]. HAEMOPHILIA, 2012, 18 (01) : E35 - E36
  • [36] CURRENT STATUS OF ANTITHROMBOTIC THERAPY IN CARDIOVASCULAR-DISEASE
    ROGERS, PH
    SHERRY, S
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 1976, 19 (03) : 2352 - 53
  • [37] GPVI inhibition: Advancing antithrombotic therapy in cardiovascular disease
    Slater, Alexandre
    Khattak, Sophia
    Thomas, Mark R.
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (05) : 465 - 473
  • [38] Cardiovascular Disease Prevention in Persons with Hemophilia
    Hardesty, Brandon
    Bowen, Joel
    Sood, Suman L.
    Kessler, Craig M.
    Janbain, Maissaa
    Escobar, Miguel
    Quon, Doris, V
    [J]. BLOOD, 2022, 140 : 10777 - 10778
  • [39] Cardiovascular Disease in Patients with Haemophilia: One Centre Experience
    Nikolaou, E.
    Kouramba, A.
    Adraktas, T.
    Kanellopoulou, G.
    Tzanogiorgis, I.
    Kotsi, P.
    Gavalaki, M.
    Katsarou, O.
    [J]. HAEMOPHILIA, 2015, 21 : 18 - 19
  • [40] Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
    Alkhalil, Mohammad
    Andreotti, Felicita
    Maggioni, Aldo P.
    Ferro, Charles J.
    Sarafidis, Pantelis
    Ortiz, Alberto
    Tsimikas, Sotirios
    Karwatowska-Prokopczuk, Ewa
    Xia, Shuting
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (21):
12345